Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

19
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats.

Brain, behavior, and immunity·2018
Same author

Adiponectin attenuates neuronal apoptosis induced by hypoxia-ischemia via the activation of AdipoR1/APPL1/LKB1/AMPK pathway in neonatal rats.

Neuropharmacology·2018
Same author

PDGFR-β modulates vascular smooth muscle cell phenotype via IRF-9/SIRT-1/NF-κB pathway in subarachnoid hemorrhage rats.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2018
Same author

Intracerebral Hemorrhage in Mice.

Methods in molecular biology (Clifton, N.J.)·2018
Same author

Editorial: Targeting Cerebral Vascular Injury for Intervention.

Current drug delivery·2018
Same author

IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats.

Journal of neuroinflammation·2018
Same journal

Real-world pharmacovigilance of drug-related bone metabolism disorders: integrating FAERS and VigiAccess with a Bradford Hill-based causal plausibility assessment.

Frontiers in pharmacology·2026
Same journal

Voriconazole therapeutic drug monitoring and safety in HIV-infected patients with invasive fungal disease.

Frontiers in pharmacology·2026
Same journal

Hepatoprotective effects of astaxanthin and kokum on lipid peroxidation and fatty acid profile in mice with diet-induced NAFLD.

Frontiers in pharmacology·2026
Same journal

Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

Frontiers in pharmacology·2026
Same journal

Cepharanthine improves blood glucose levels and mitigates renal injury in streptozotocin-induced diabetic rats via restoring pancreatic β-cell integrity and reducing inflammation.

Frontiers in pharmacology·2026
Same journal

Integrative management of gastric cardia cancer and precancerous lesions: prospects and mechanistic rationale for Banxia Xiexin Tang.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: Aug 8, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K

Delayed revascularization in acute ischemic stroke patients.

T Marc Eastin1, Justin A Dye1, Promod Pillai1

  • 1Department of Neurological Surgery, Loma Linda University Medical Center, Loma Linda, CA, United States.

Frontiers in Pharmacology
|February 27, 2023
PubMed
Summary
This summary is machine-generated.

Delayed revascularization for ischemic stroke shows promise beyond the acute phase. Advances in neuroimaging and devices expand treatment windows, improving outcomes for more patients.

Keywords:
delayed revascularizationischemic strokepenumbrarevascularizationstrokethrombectomythrombolysis

More Related Videos

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K

Related Experiment Videos

Last Updated: Aug 8, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Neuroradiology

Background:

  • Stroke is a leading cause of mortality and disability worldwide.
  • Post-stroke cognitive impairment significantly reduces quality of life.
  • Current revascularization therapies are limited to the acute phase, excluding many patients.

Purpose of the Study:

  • To review the current understanding of ischemic stroke.
  • To discuss the evolving revascularization doctrine.
  • To present evidence for effective delayed revascularization in ischemic stroke.

Main Methods:

  • Review of current literature on ischemic stroke and revascularization.
  • Analysis of advances in neuroimaging and interventional devices.
  • Examination of clinical studies on delayed revascularization outcomes.

Main Results:

  • Neuroimaging advances improve assessment of salvageable brain tissue.
  • Interventional devices like stent retrievers expand the revascularization window.
  • Clinical studies support positive outcomes for delayed revascularization.

Conclusions:

  • Delayed revascularization offers a viable treatment option for ischemic stroke patients.
  • Technological advancements are crucial in expanding therapeutic opportunities.
  • Further research is needed to optimize delayed treatment strategies.